Lv4
456 积分 2025-12-17 加入
Guideline of the Czech Hepatology Society of the ČLS JEP for diagnosis and treatment of non-alcoholic fatty liver disease
5天前
已关闭
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group
5天前
已完结
S2635 Rising Trends and Mortality Predictors in MASLD-Associated Cirrhosis: A Nationwide Analysis
6天前
已完结
The evaluation of complications and mortality in non-alcoholic steatohepatitis-related cirrhosis
6天前
已关闭
Tu1630 ALCOHOLIC CIRRHOSIS IS ASSOCIATED WITH INCREASED MORTALITY, MORBIDITY, AND DECOMPENSATION EVENTS COMPARED TO NONALCOHOLIC CIRRHOSIS
6天前
已完结
Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD
11天前
已完结
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
13天前
已完结
Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study
13天前
已完结
Head-to-head comparison between vibration-controlled transient elastography and histology in predicting liver-related events due to metabolic dysfunction-associated steatotic liver disease
1个月前
已完结
Meta‐Analysis: Global Prevalence and Mortality of Cirrhosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease
1个月前
已完结
皖公网安备34019202002308
